Status:
WITHDRAWN
Using Continuous Positive Airway Pressure to Reduce the Incidence of Acute Kidney Injury in Hospitalized Patients With Chronic Kidney Disease
Lead Sponsor:
University of South Florida
Conditions:
Chronic Kidney Disease
Obstructive Sleep Apnea
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Obstructive sleep apnea (OSA) is a common and undertreated condition in patients with chronic kidney disease (CKD). Both physiologic and empiric data suggest that renal hypoxia due to OSA is associate...
Eligibility Criteria
Inclusion
- CKD defined by National Kidney Foundation Staging system: eGFR \< 60
- Overnight sleep study consistent with OSA
Exclusion
- Currently treated with positive airway pressure for sleep-disordered breathing
- Hemodynamically unstable, defined as SBP \< 90, or use of vasopressors
- Intubated or mechanically ventilated
- Respiratory insufficiency, defined as P/F ratio \< 250, or requiring mechanical ventilation
- End stage renal disease on renal replacement therapy
- Contraindication to CPAP, including active emesis, recent intracranial surgery, altered level of consciousness
Key Trial Info
Start Date :
May 30 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01859260
Start Date
May 30 2013
End Date
July 1 2014
Last Update
April 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampa general hospital
Tampa, Florida, United States, 33606